Berberine attenuates ischemia-reperfusion injury through inhibiting HMGB1 release and NF-κB nuclear translocation. [electronic resource]
- Acta pharmacologica Sinica Nov 2018
- 1706-1715 p. digital
Publication Type: Journal Article
1745-7254
10.1038/s41401-018-0160-1 doi
Animals Berberine--therapeutic use Brain--pathology Brain Edema--drug therapy Down-Regulation Glycyrrhizic Acid--therapeutic use HMGB1 Protein--antagonists & inhibitors Infarction, Middle Cerebral Artery--drug therapy Interleukin-1beta--metabolism Interleukin-6--metabolism Male Mice, Inbred C57BL NF-kappa B p50 Subunit--antagonists & inhibitors Neuroprotective Agents--therapeutic use Reperfusion Injury--complications Signal Transduction--drug effects Toll-Like Receptor 4--genetics Tumor Necrosis Factor-alpha--metabolism